Compile Data Set for Download or QSAR

Found 6 hits Enz. Inhib. hit(s) with Target = 'Nuclear receptor ROR-gamma' and Ligand = 'BDBM317903'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Nuclear receptor ROR-gamma (Homo sapiens (Human))	BDBM317903 (US10399976, Compound 56 | US10807980, Compound 56 ...) Show SMILES CCS(=O)(=O)c1ccc(CC(=O)Nc2cnc3[C@H](C(C)C)N(Cc4ccc(Cl)cc4)Cc3c2)cc1 |r| Show InChI InChI=1S/C27H30ClN3O3S/c1-4-35(33,34)24-11-7-19(8-12-24)13-25(32)30-23-14-21-17-31(16-20-5-9-22(28)10-6-20)27(18(2)3)26(21)29-15-23/h5-12,14-15,18,27H,4,13,16-17H2,1-3H3,(H,30,32)/t27-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	<100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Vitae Pharmaceuticals, Inc. US Patent					Assay Description Compounds of the present invention were tested for ability to bind to RORγ in a cell-free competition assay with commercially available radio-li...				US Patent US9624217 (2017) BindingDB Entry DOI: 10.7270/Q29P33RJ
					More data for this Ligand-Target Pair
Nuclear receptor ROR-gamma (Homo sapiens (Human))	BDBM317903 (US10399976, Compound 56 | US10807980, Compound 56 ...) Show SMILES CCS(=O)(=O)c1ccc(CC(=O)Nc2cnc3[C@H](C(C)C)N(Cc4ccc(Cl)cc4)Cc3c2)cc1 |r| Show InChI InChI=1S/C27H30ClN3O3S/c1-4-35(33,34)24-11-7-19(8-12-24)13-25(32)30-23-14-21-17-31(16-20-5-9-22(28)10-6-20)27(18(2)3)26(21)29-15-23/h5-12,14-15,18,27H,4,13,16-17H2,1-3H3,(H,30,32)/t27-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	<100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Vitae Pharmaceuticals, LLC US Patent					Assay Description Compounds of the present invention were tested for ability to bind to ROR gamma in a cell-free competition assay with commercially available radio-li...				US Patent US10399976 (2019) BindingDB Entry DOI: 10.7270/Q2F76FXT
					More data for this Ligand-Target Pair
Nuclear receptor ROR-gamma (Homo sapiens (Human))	BDBM317903 (US10399976, Compound 56 | US10807980, Compound 56 ...) Show SMILES CCS(=O)(=O)c1ccc(CC(=O)Nc2cnc3[C@H](C(C)C)N(Cc4ccc(Cl)cc4)Cc3c2)cc1 |r| Show InChI InChI=1S/C27H30ClN3O3S/c1-4-35(33,34)24-11-7-19(8-12-24)13-25(32)30-23-14-21-17-31(16-20-5-9-22(28)10-6-20)27(18(2)3)26(21)29-15-23/h5-12,14-15,18,27H,4,13,16-17H2,1-3H3,(H,30,32)/t27-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	<100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Compounds of the present invention were tested for ability to bind to RORγ in a cell-free competition assay with commercially available radio-li...				Citation and Details BindingDB Entry DOI: 10.7270/Q2BK1H79
					More data for this Ligand-Target Pair
Nuclear receptor ROR-gamma (Homo sapiens (Human))	BDBM317903 (US10399976, Compound 56 | US10807980, Compound 56 ...) Show SMILES CCS(=O)(=O)c1ccc(CC(=O)Nc2cnc3[C@H](C(C)C)N(Cc4ccc(Cl)cc4)Cc3c2)cc1 |r| Show InChI InChI=1S/C27H30ClN3O3S/c1-4-35(33,34)24-11-7-19(8-12-24)13-25(32)30-23-14-21-17-31(16-20-5-9-22(28)10-6-20)27(18(2)3)26(21)29-15-23/h5-12,14-15,18,27H,4,13,16-17H2,1-3H3,(H,30,32)/t27-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	<100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Vitae Pharmaceuticals, LLC US Patent					Assay Description Compounds of the present invention were tested for ability to bind to RORγ in a cell-free competition assay with commercially available radio-li...				US Patent US10807980 (2020) BindingDB Entry DOI: 10.7270/Q2PR803S
					More data for this Ligand-Target Pair
Nuclear receptor ROR-gamma (Homo sapiens (Human))	BDBM317903 (US10399976, Compound 56 | US10807980, Compound 56 ...) Show SMILES CCS(=O)(=O)c1ccc(CC(=O)Nc2cnc3[C@H](C(C)C)N(Cc4ccc(Cl)cc4)Cc3c2)cc1 |r| Show InChI InChI=1S/C27H30ClN3O3S/c1-4-35(33,34)24-11-7-19(8-12-24)13-25(32)30-23-14-21-17-31(16-20-5-9-22(28)10-6-20)27(18(2)3)26(21)29-15-23/h5-12,14-15,18,27H,4,13,16-17H2,1-3H3,(H,30,32)/t27-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	550	n/a	n/a	n/a	n/a	n/a	n/a
Vitae Pharmaceuticals, LLC US Patent					Assay Description Compounds of the present invention were tested for RORγ inverse agonist activity in a cell-based, transcriptional activity assay. Secreted Nanol...				US Patent US10807980 (2020) BindingDB Entry DOI: 10.7270/Q2PR803S
					More data for this Ligand-Target Pair
Nuclear receptor ROR-gamma (Homo sapiens (Human))	BDBM317903 (US10399976, Compound 56 | US10807980, Compound 56 ...) Show SMILES CCS(=O)(=O)c1ccc(CC(=O)Nc2cnc3[C@H](C(C)C)N(Cc4ccc(Cl)cc4)Cc3c2)cc1 |r| Show InChI InChI=1S/C27H30ClN3O3S/c1-4-35(33,34)24-11-7-19(8-12-24)13-25(32)30-23-14-21-17-31(16-20-5-9-22(28)10-6-20)27(18(2)3)26(21)29-15-23/h5-12,14-15,18,27H,4,13,16-17H2,1-3H3,(H,30,32)/t27-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	550	n/a	n/a	n/a	n/a	n/a	n/a
Vitae Pharmaceuticals, LLC US Patent					Assay Description Compounds of the present invention were tested for ROR gamma inverse agonist activity in a cell-based, transcriptional activity assay. Secreted Nanol...				US Patent US10399976 (2019) BindingDB Entry DOI: 10.7270/Q2F76FXT
					More data for this Ligand-Target Pair